Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine (retiring September 1, 2026), Johnson & Johnson
In the news
Jennifer Taubert to retire; Tom Cavanaugh named head of Innovative Medicine
Johnson & Johnson said Executive Vice President Jennifer Taubert will retire after more than 21 years, and Tom Cavanaugh will succeed her as Executive Vice President and Worldwide Chairman of Innovative Medicine.
Management